Cystic Fibrosis Is Treatment with Ursodeoxycholic Acid of Value?

References

• Cystic fibrosis, M E Hodson, A P Norman, J C Batten. Bailliére & Tindall, London 1983
   Google Scholar
• Kerem B-S, Rommens J M, Buchanan J A, Markiewicz D, Cox T K, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073–80
   PubMed Web of Science ®Google Scholar
• Riordan J R, Rommens J M, Kerem B, Alon N, Rozmahel R, Grzelczak Z, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary cDNA. Science 1989; 245: 1066–72
   PubMed Web of Science ®Google Scholar
• Duthie A, Doherty D G, Williams C, Scott-Jupp R, Warner J O, Tanner M S, et al. Genotype analysis for A F508, G551D and R553X mutations in children and young adults with cystic fibrosis with and without chronic liver disease. Hepatology 1992; 15: 660–4
   PubMedGoogle Scholar
• Psacharopoulos H T, Howard E R, Portmann B, Mowat A P, Williams R. Hepatic complications of cystic fibrosis. Lancet 1981; 2: 78–80
   PubMed Web of Science ®Google Scholar
• Tanner M S. Liver and biliary problems in cystic fibrosis. J Roy Soc Med 1992; 85(Suppl 19)20–4
   PubMedGoogle Scholar
• Stern R C, Stevens D P, Boat T F, Doershuk C F, Izant R J, Jr, Matthews L W. Symptomatic hepatic disease in cystic fibrosis: incidence, course, and outcome of portal systemic shunting. Gastroenterology 1976; 70: 645–9
   PubMedGoogle Scholar
• Mieles L A, Orenstein D, Teperman L, Podesta L, Koneru B, Starzl T E. Liver transplantation in cystic fibrosis. Lancet 1989; 1: 1073
   PubMedGoogle Scholar
• Valman H B, France N E, Wallis P G. Prolonged neonatal jaundice in cystic fibrosis. Arch Dis Child 1971; 46: 805–9
   PubMedGoogle Scholar
• di Sant'Agnese P A, Blanc W A. A distinctive type of biliary cirrhosis of the liver associated with cystic fibrosis of the pancreas. Pediatrics 1956; 18: 387–409
   PubMed Web of Science ®Google Scholar
• Craig J M, Haddad H, Shwachman H. The pathological changes in the liver in cystic fibrosis of the pancreas. Am J Dis Child 1957; 93: 357–69
   Google Scholar
• Oppenheimer E H, Esterly J R. Pathology of cystic fibrosis. Review of the literature and comparison with 146 autopsied cases. Persp Paediatr Pathol 1975; 2: 241–78
   PubMedGoogle Scholar
• Strandvik B, Hjelte L, Gabrielsson N, Glaumann H. Sclerosing cholangitis in cystic fibrosis. Scand J Gastroenterol 1988; 23(Suppl 143)121–4
   PubMedGoogle Scholar
• Kattwinkel J, Taussig L M, Statland B E, Verter J I. The effects of age on alkaline phosphatase and other serologic liver function tests in normal subjects and patients with cystic fibrosis. J Pediatr 1973; 82: 234–42
   PubMed Web of Science ®Google Scholar
• Strandvik B, Samuelsson K. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis. Scand J Gastroenterol 1985; 20: 381–4
   PubMed Web of Science ®Google Scholar
• L'Heureux P R, Isenberg J N, Sharp H L, Warwick W J. Gallbladder disease in cystic fibrosis. Am J Roentgenol 1977; 128: 953–6
   PubMedGoogle Scholar
• Santamaria F, Vajro P, Oggero V, Greco L, Angelillo M, Carrillo F, et al. Volume and emptying of the gallbladder in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1990; 10: 303–6
   PubMedGoogle Scholar
• Abdul-Karim F W, King T A, Dahms B B, Gauderer M WL, Boat T F. Carcinoma of extrahepatic biliary system in an adult with cystic fibrosis. Gastroenterology 1982; 82: 758–62
   PubMed Web of Science ®Google Scholar
• Watkins J B, Tercyak A M, Szczepanik P, Klein P D. Bile salt kinetics in cystic fibrosis: influence of pancreatic enzyme replacement. Gastroenterology 1977; 73: 1023–8
   PubMed Web of Science ®Google Scholar
• Strandvik B, Angelin B, Einarsson K. Bile acid kinetics and bile lipid composition in cystic fibrosis. Scand J Gastroenterol 1988; 23(Suppl 143)166, (abstract)
   Google Scholar
• Fondacaro J D, Heubi J E, Kellogg F W. Intestinal bile acid malabsorption in cystic fibrosis: a primary mucosal cell defect. Pediatr Res 1982; 16: 494–8
   PubMed Web of Science ®Google Scholar
• Roller R J, Kern F, Jr. Minimal bile acid malabsorption and normal bile acid breath tests in cystic fibrosis and acquired pancreatic insufficiency. Gastroenterology 1977; 72: 661–5
   PubMed Web of Science ®Google Scholar
• Goodchild M C, Murphy G M, Howell A M, Nutter S A, Anderson C M. Aspects of bile acid metabolism in cystic fibrosis. Arch Dis Child 1975; 50: 769–78
   PubMed Web of Science ®Google Scholar
• Strandvik B, Norman A, Eklund A. Bile acid excretion in cystic fibrosis. Bile acid metabolism in health and disease, G Paumgartner, A Stiehl. MTP Press, LancasterUK 1977; 241–6
   Google Scholar
• Eklund A, Norman A, Strandvik B. Excretion of bile acids in urine in healthy children and in children with cystic fibrosis. Scand J Clin Lab Invest 1980; 40: 595–608
   PubMed Web of Science ®Google Scholar
• Harries J T, Muller D PR, McCollum P K, Lipson A, Roma E, Norman A P. Intestinal bile salts in cystic fibrosis. Arch Dis Child 1979; 54: 19–24
   PubMed Web of Science ®Google Scholar
• Strandvik B, Hjelte L. Nephrolithiasis in cystic fibrosis. Acta Paediatr 1993; 82: 306–7
   PubMedGoogle Scholar
• Sahl B, Howat J, Webb K. Ursodeoxycholic acid dissolution in gallstones in cystic fibrosis. Thorax 1988; 43: 490–1
   PubMedGoogle Scholar
• Colombo C, Bertolini E, Assaisso M L, Bettinardi N, Giunta A, Podda M. Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis. Acta Paediatr 1993; 82: 562–5
   PubMed Web of Science ®Google Scholar
• Colombo C, Roda A, Roda E, Sereni L P, Maspero D, Giunta A, et al. Evaluation of an oral ursodeoxycholic acid load in the assessment of bile acid malabsorption in cystic fibrosis. Dig Dis Sci 1983; 28: 306–11
   PubMedGoogle Scholar
• Colombo C, Crosignani A, Assaisso M, Battezzati P M, Podda M, Giunta A, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology 1992; 16: 924–30
   PubMedGoogle Scholar
• Colombo C, Setchell K DR, Podda M, Crosignani A, Roda A, Curcio L, et al. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. J Pediatr 1990; 117: 482–9
   PubMed Web of Science ®Google Scholar
• Galabert C, Montet J C, Lengrand D, Lecuire A, Sotta C, Figarella C, et al. Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasis. J Pediatr 1992; 121: 138–41
   PubMedGoogle Scholar
• Nakagawa M, Colombo C, Setchell K DR. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration. Hepatology 1990; 12: 322–34
   PubMedGoogle Scholar
• Galabert C, Lengrand D, Montet J C, Dimier J L, Chazalette J P. Utilisation de l'acide ursodésoxycholique dans le traitement des complications hépato-biliaires de la mucoviscidose. Path Biol 1991; 39: 625–8
   PubMedGoogle Scholar
• Cotting J, Lentze M J, Reichen J. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis. Gut 1990; 31: 918–21
   PubMedGoogle Scholar
• Colombo C, Castellani M R, Balistreri W F, Seregni E, Assaisso M L, Giunta A. Scintigraphic documentation of an improvement in hepatobiliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 1992; 15: 677–84
   PubMed Web of Science ®Google Scholar
• Feigelson J, Anagnostopoulos C, Poquet M, Pecau Y, Munck A, Navarro J. Liver cirrhosis in cystic fibrosis-therapeutic implications and long-term follow-up. Arch Dis Child 1993; 68: 653–7
   PubMedGoogle Scholar
• Lindblad A, Strandvik B. Long-term study of the effect of ursodeoxycholic acid on liver morphology and liver function in patients with CF. 18th Eur CF Conf. Madrid 1993; 89, (abstract)
   Google Scholar
• Yang Y, Raper S E, Cohn J A, Engelhardt J F, Wilson J M. An approach for treating the hepatobiliary disease of cystic fibrosis by somatic gene transfer. Proc Natl Acad Sci USA 1993; 90: 4601–5
   PubMedGoogle Scholar